ArticleScientific reports2025
Short-term natural history of macular neovascularization in nonexudative age-related macular degeneration using multimodal imaging.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Macular degeneration collection.Scientific reports · 2026Article
- Non-Exudative Macular Neovascularization in Various Acquired Macular Degenerations with Double- and Triple-Layer Sign on OCT.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The short-term conversion rate of a non-exudative macular neovascularization (ne-MNV) to an exudative stage in age-related macular degeneration (AMD) was evaluated in a single-center, retrospective case control study and associated imaging characteristics described, using multimodal imaging. A total of 241 Caucasian patients with unilateral, treatment-naive exudative neovascular AMD were screened for the presence of a ne-MNV in the fellow eye between March 2016 and May 2022. Eyes with a confirmed ne-MNV on indocyanine green angiography and/or optical coherence tomography angiography (OCTA) were monitored using structural OCT for signs of exudation. The main outcome was to evaluate multimodal imaging biomarkers to identify predictors of exudative conversion.Among 241 study eyes, 40 (16.6%) showed ne-MNV at baseline, all classified as type 1 MNV. During follow-up, 13 patients (32.5%) progressed to an exudative stage, with a mean time to exudation of 12.6 months (range: 2.6-22.4 months). The presence of a shallow irregular retinal pigment epithelial elevation (SIRE) was the only statistically significant feature associated with an increased risk of conversion to exudation. (p = 0.012) Patients with ne-MNV and a baseline SIRE are at increased risk for exudation. SIRE can be easily identified and followed up with structural OCT, providing a valuable marker for monitoring ne-MNV activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.